Ovarian Cancer Trial, Recruiting NCT06640348 Sponsor: Anhui Provincial Hospital Condition: Ovarian Cancer
Back to Ovarian Cancer

Ovarian Cancer Trial, Recruiting

NCT06640348
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who understand what the trial involves, are willing to take part, and are able to follow the study requirements (including signing a consent form)
  • People aged 18 to 70 years old (inclusive)
  • Cancer group — People diagnosed with one of the following types of ovarian cancer: high-grade serous ovarian cancer, low-grade serous ovarian cancer, endometrioid ovarian cancer, or clear cell carcinoma, who are starting treatment for the first time and have complete medical records
  • Cancer group participants must have a general health/activity level rated between 0 and 3 on a standard scale, and a life expectancy of more than 6 months (confirm with trial site)
  • Cancer group participants must be willing to have a blood sample taken for a special type of analysis called SERS, which is provided free of charge
  • Cancer group participants must have organs that are functioning well enough to meet the study requirements
  • Normal control group — People who are having surgery for a non-cancerous (benign) condition, have complete medical records, and have not had any major treatment for that benign condition before the blood sample is taken

Who may not be able to join:

  • People with severe or uncontrolled health conditions, such as uncontrollable nausea or vomiting, serious digestive problems, serious heart disease, certain infections (including syphilis, HIV/AIDS, active hepatitis B or C), active abscesses, active rheumatic diseases, or mental health conditions that would prevent a person from signing the consent form
  • People who have had a blood transfusion within the 4 weeks before the study begins
  • People who are pregnant, have recently given birth, are breastfeeding, or plan to become pregnant during the study
  • People who have a history of any other type of cancer
  • People whom the trial doctor considers unsuitable for participation for any other reason

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: _8613865901025

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Anhui Provincial Hospital
Registry
ClinicalTrials.gov
Start date
1 January 2025
Est. completion
31 December 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

PFS PFS; OS

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov